Publications by authors named "S Deas"
Article Synopsis
- The COVID-19 pandemic has created a major crisis affecting population health, the economy, and society, particularly impacting vulnerable groups such as those in poverty, precarious employment, women, elderly individuals, and BAME communities.
- There is a wealth of literature suggesting that plural ownership could foster a more inclusive economy, but a comprehensive analysis of its actual impacts is lacking and necessary.
- This review will analyze evidence from various sectors, focusing on the effects of plural ownership on access to opportunities, distribution of benefits, poverty, and discrimination, using a thorough and systematic research approach.
Background: Reports indicate social distancing guidelines and other effects of the COVID-19 pandemic impacted trauma patient volumes and injury patterns. This report is the first analysis of a large trauma network describing the extent of these impacts. The objective of this study was to describe the effects of the COVID-19 pandemic on patient volumes, demographics, injury characteristics, and outcomes.
View Article and Find Full Text PDFIntroduction: As the COVID-19 pandemic spread, patient care guidelines were published and elective surgeries postponed. However, trauma admissions are not scheduled and cannot be postponed. There is a paucity of information available on continuing trauma care during the pandemic.
View Article and Find Full Text PDFBackground: Psychological stress during pregnancy has been shown to cause subsequent harm to the fetus and newborn. Many studies focus on neurodevelopmental outcomes, but little is known about the effect of gestational stress on intestinal immunity and development. The purpose of this study was to determine the effect of psychological stress during pregnancy on intestinal architecture and growth in newborns.
View Article and Find Full Text PDFPurpose Of Review: Recent updates to the GOLD guidelines emphasize the use of combination LABA and LAMA bronchodilators for patients with chronic obstructive pulmonary disease with persistent dyspnea despite monotherapy or frequent exacerbations despite LAMA monotherapy. There are several commercially available LABA/LAMA fixed dose combination inhalers, which are likely to become the principle therapy for many patients with COPD.
Recent Findings: In the last 4 years, there have been a number of large clinical trials evaluating the efficacy and safety of combined LAMA and LABA bronchodilators.